How to stop Wegovy without gaining the weight back

What STEP trial follow-up data actually tell us about stopping semaglutide

The most cited figure comes from the STEP 1 extension study: one year after semaglutide was withdrawn, participants had regained roughly two-thirds of the weight they had lost during the trial. That is a large number, and it has understandably alarmed people. But it reflects a specific scenario (discontinuation with no structured support) rather than an inevitable biological verdict.

The regain happens for a straightforward physiological reason. Semaglutide works by activating GLP-1 receptors that reduce appetite and slow gastric emptying, described in detail on our explanation of how Wegovy works. Once the drug clears your system, those receptor signals fade. If eating habits have not changed independently of the medication's appetite suppression, caloric intake tends to drift back towards pre-treatment levels. The body's energy-regulating hormones also partially revert, which is a recognised feature of obesity biology rather than a character failing.

This is why the NHS England guidance on weight-management injections places such emphasis on behavioural and dietary support alongside the medicine. The drug is an adjunct to change, not a substitute for it. If that context has been missing from your treatment, building it now (before you stop) gives you a measurably better outcome.

Building the habits that outlast the prescription

A question our prescribers hear most weeks is some version of: "Can I keep the weight off without staying on Wegovy forever?" The honest answer is yes, for many people, but the conditions that make that possible are not created by the drug.

The practical priorities are protein adequacy, resistance training and consistent sleep. Adequate dietary protein (broadly 1.2–1.6 g per kilogram of body weight, though your prescriber or a dietitian should guide your specific target) preserves muscle during weight loss and reduces the speed of regain when a caloric appetite returns. Muscle tissue is metabolically active; losing it during treatment makes regain easier and more rapid. You can read more about the relationship between diet and weight-loss medicine on our weight-loss overview.

Resistance exercise (two to three sessions a week covering the major muscle groups) has a compounding effect: it maintains lean mass, raises resting metabolic rate slightly, and appears to blunt some of the hormonal rebound associated with GLP-1 withdrawal. Sleep is less frequently mentioned but strongly supported: chronic poor sleep elevates ghrelin and lowers leptin, recreating the hunger environment that made weight management harder before treatment.

These are habits worth starting on Wegovy, not waiting until you stop. We cover the specific strategies in more detail for anyone wondering how to not gain weight after Wegovy, including what the evidence says about diet, exercise and timing relative to when you stop the medicine. The appetite suppression the drug provides is arguably the best window you will ever have to build them without fighting constant hunger.

How stopping compares to continuing, and what to discuss with your prescriber

Not everyone stops Wegovy by choice. Some people reach a treatment plateau and wonder whether the medicine is still doing useful work; others face cost considerations. Our Wegovy pricing page covers what private treatment typically costs and what the components of a legitimate price should include, which is useful context for that conversation.

NICE's appraisal of semaglutide for weight management, TA875, recommends a maximum treatment duration of two years within specialist services, partly because evidence beyond that window is limited, partly because the long-term goal is sustainable independent weight management. That two-year limit does not mean everyone must stop at the same point, and private prescribing follows the licensed indications rather than NICE's NHS commissioning criteria; the point is that planned endpoints are clinically considered, not arbitrary.

If you are thinking about how to approach stopping Wegovy, the most productive conversation with your prescriber will cover: what weight has been maintained on the current dose, whether a slow taper or direct stop suits your situation, and what monitoring plan will be in place once you have stopped. Weight slowly creeping up after stopping is not failure, it is information, and catching it early means options remain open.

For anyone already noticing weight returning after stopping, the evidence supports acting on that early rather than waiting for the full pre-treatment weight to return before re-engaging with support or clinical review. It is also worth being aware that some people find they gain weight on Wegovy itself, whether due to dose, timing or other factors, and understanding why that happens can inform how you approach the period after stopping. The longer regain goes unaddressed, the harder it is to reverse.